{"id":9640,"date":"2026-11-20T12:33:36","date_gmt":"2026-11-20T11:33:36","guid":{"rendered":"https:\/\/www.pjpharma.it\/?p=9640"},"modified":"2026-11-20T12:43:34","modified_gmt":"2026-11-20T11:43:34","slug":"secol-antireflux-clinical-study-reflux-heartburn","status":"publish","type":"post","link":"https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/","title":{"rendered":"Secol Antireflux: clinical study on reflux and heartburn"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Secol Antireflux for heartburn and reflux: clinical study results with the GERD-HRQL questionnaire<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.pjpharma.it\/en\/product\/secol-antireflux\/\"><strong>Secol Antireflux<\/strong><\/a> <strong>for reflux and heartburn<\/strong> is designed to support the management of common gastroesophageal reflux symptoms: <strong>acid regurgitation, heartburn<\/strong>, discomfort when lying down, <strong>night-time awakenings<\/strong> and, when associated, <strong>reflux-related cough and bloating<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In the <strong>clinical study<\/strong>, changes in symptoms were assessed using the <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17439596\/\"><strong>GERD-HRQL questionnaire<\/strong><\/a>, a tool used in clinical research to systematically assess the impact of reflux on quality of life.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.pjpharma.it\/en\/product\/secol-antireflux\/\"><strong>Secol Antireflux<\/strong><\/a> is available as an <strong>oral gel<\/strong> in 210 ml or 300 ml bottles, supplied with a syringe adapter and a dosing syringe.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/farmaimpresa.com\/en\/gfi-extends-mdd-certificate-for-gerd-devices\/\">All our medical devices for managing gastroesophageal reflux are under <strong>MDD extension<\/strong>, reflecting a structured regulatory and qualification programme in the GERD area.<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>The data refer to an observational clinical study conducted by Gruppo Farmaimpresa in August 2025<\/em>, evaluating Secol Antireflux in the management of gastroesophageal reflux symptoms and heartburn and assessing their impact on quality of life using a dedicated clinical questionnaire.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">What is Secol Antireflux and how does it differ from a simple antacid?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.pjpharma.it\/en\/product\/secol-antireflux\/\"><strong>Secol Antireflux<\/strong><\/a> is an <strong>oral gel<\/strong> containing magnesium alginate and simethicone, designed to support people who occasionally experience symptoms of <strong>gastroesophageal reflux<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It combines two complementary physical mechanisms in a <strong>dual-action system<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Magnesium alginate:<\/strong> helps form a <strong>protective barrier<\/strong>, helping counter <strong>acid regurgitation<\/strong>.<\/li>\n\n\n\n<li><strong>Simethicone:<\/strong> reduces the <strong>surface tension<\/strong> of gas bubbles in gastric contents, facilitating their elimination and providing support when reflux is accompanied by <strong>bloating<\/strong> and <strong>abdominal distension<\/strong>.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Who is Secol Antireflux indicated for?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.pjpharma.it\/en\/product\/secol-antireflux\/\"><strong>Secol Antireflux<\/strong><\/a> supports the management of recurring discomfort caused by reflux and excess acidity, which can affect everyday well-being and sleep. It is particularly relevant when typical reflux symptoms are accompanied by bloating, gas, abdominal heaviness and tension.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Indications include:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Gastroesophageal reflux disease (GERD)<\/li>\n\n\n\n<li>Reflux esophagitis<\/li>\n\n\n\n<li>Heartburn<\/li>\n\n\n\n<li>Reflux-related cough<\/li>\n\n\n\n<li>Abdominal pain or cramps associated with excess acidity and bloating.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Secol Antireflux clinical study: methodology and results<\/h2>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/farmaimpresa.com\/wp-content\/uploads\/2026\/06\/download-22.png\" alt=\"Secol Antireflux GERD-HRQL scores at baseline and after four weeks\"\/><figcaption class=\"wp-element-caption\">Comparison of GERD-HRQL scores at baseline and after four weeks.<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The observational study enrolled <strong>20 adults<\/strong>. Symptoms were reassessed at follow-up after <strong>4 weeks<\/strong> (T1) and compared with baseline (T0). During the study, the daily dose was 15 ml.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The GERD-HRQL score chart shows a marked reduction between T0 and T1, with a statistically significant difference (<strong>p &lt; 0.001<\/strong>). This reflects an observed improvement in typical reflux symptoms, including heartburn and associated discomfort, and in quality of life.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">How much did patients improve?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The report indicates that <strong>75% of patients<\/strong> achieved a <strong>reduction of at least 50% in their GERD-HRQL score<\/strong>. With one exception, participants also reduced their scores to lower severity levels.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Specific symptoms: what changed in everyday life?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">In addition to the overall score, the report highlights a substantial decrease in symptom frequency. In particular, <strong>night-time awakenings due to heartburn<\/strong>, <strong>difficulty swallowing<\/strong> and <strong>pain when swallowing<\/strong> were almost completely absent at follow-up (T1). Overall health perception also improved, with many participants moving from dissatisfaction to a satisfied or neutral assessment. As this was an observational study without a control group, the findings cannot establish causality.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Looking for a ready-to-market or private label solution for B2B distribution?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">We are certified manufacturers of medical devices, food supplements and cosmetics. <strong>Secol Antireflux<\/strong> is available for market launch or private label, with regulatory and clinical support.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/farmaimpresa.com\/en\/contacts\/\">Contact us<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Observational clinical study involving 20 adults with gastroesophageal reflux. After 4 weeks, 75% of patients achieved a reduction of at least 50% in their GERD-HRQL score (overall comparison: p < 0.001).\n<\/p>\n","protected":false},"author":3,"featured_media":9641,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[412],"tags":[2195,2773,3177,2772,3176],"class_list":["post-9640","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clinical-studies","tag-clinical-study","tag-gastroesophageal-reflux","tag-gerd-hrql","tag-heartburn","tag-secol-antireflux"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Secol Antireflux: Clinical Study on Reflux and Heartburn<\/title>\n<meta name=\"description\" content=\"Secol Antireflux clinical study: after 4 weeks, 75% of 20 adults achieved a reduction of at least 50% in their GERD-HRQL score.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Secol Antireflux: Clinical Study on Reflux and Heartburn\" \/>\n<meta property=\"og:description\" content=\"Secol Antireflux clinical study: after 4 weeks, 75% of 20 adults achieved a reduction of at least 50% in their GERD-HRQL score.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/\" \/>\n<meta property=\"og:site_name\" content=\"PJ PHARMA\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-20T11:33:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-20T11:43:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pjpharma.it\/wp-content\/uploads\/2026\/11\/Secol-Antireflusso-studio-clinico-su-reflusso-e-bruciore-1920x960-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"giusy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"giusy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/secol-antireflux-clinical-study-reflux-heartburn\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/secol-antireflux-clinical-study-reflux-heartburn\\\/\"},\"author\":{\"name\":\"giusy\",\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/#\\\/schema\\\/person\\\/68d46a7f1517c6578046391a7778943d\"},\"headline\":\"Secol Antireflux: clinical study on reflux and heartburn\",\"datePublished\":\"2026-11-20T11:33:36+00:00\",\"dateModified\":\"2026-11-20T11:43:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/secol-antireflux-clinical-study-reflux-heartburn\\\/\"},\"wordCount\":543,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/secol-antireflux-clinical-study-reflux-heartburn\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pjpharma.it\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Secol-Antireflusso-studio-clinico-su-reflusso-e-bruciore-1920x960-1.webp\",\"keywords\":[\"Clinical study\",\"gastroesophageal reflux\",\"GERD-HRQL\",\"heartburn\",\"Secol Antireflux\"],\"articleSection\":[\"Clinical Studies\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/secol-antireflux-clinical-study-reflux-heartburn\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/secol-antireflux-clinical-study-reflux-heartburn\\\/\",\"url\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/secol-antireflux-clinical-study-reflux-heartburn\\\/\",\"name\":\"Secol Antireflux: Clinical Study on Reflux and Heartburn\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/secol-antireflux-clinical-study-reflux-heartburn\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/secol-antireflux-clinical-study-reflux-heartburn\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pjpharma.it\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Secol-Antireflusso-studio-clinico-su-reflusso-e-bruciore-1920x960-1.webp\",\"datePublished\":\"2026-11-20T11:33:36+00:00\",\"dateModified\":\"2026-11-20T11:43:34+00:00\",\"description\":\"Secol Antireflux clinical study: after 4 weeks, 75% of 20 adults achieved a reduction of at least 50% in their GERD-HRQL score.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/secol-antireflux-clinical-study-reflux-heartburn\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/secol-antireflux-clinical-study-reflux-heartburn\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/secol-antireflux-clinical-study-reflux-heartburn\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pjpharma.it\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Secol-Antireflusso-studio-clinico-su-reflusso-e-bruciore-1920x960-1.webp\",\"contentUrl\":\"https:\\\/\\\/www.pjpharma.it\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/Secol-Antireflusso-studio-clinico-su-reflusso-e-bruciore-1920x960-1.webp\",\"width\":1920,\"height\":960},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/secol-antireflux-clinical-study-reflux-heartburn\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Secol Antireflux: clinical study on reflux and heartburn\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/\",\"name\":\"PJPharma\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/#organization\",\"name\":\"PJPharma\",\"url\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.pjpharma.it\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/LOGO_PJ-17.png\",\"contentUrl\":\"https:\\\/\\\/www.pjpharma.it\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/LOGO_PJ-17.png\",\"width\":708,\"height\":700,\"caption\":\"PJPharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/#\\\/schema\\\/person\\\/68d46a7f1517c6578046391a7778943d\",\"name\":\"giusy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e7dc775e86376ea9e71a78c2adaddfe1152888fd4674ed35b3eed755d49da472?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e7dc775e86376ea9e71a78c2adaddfe1152888fd4674ed35b3eed755d49da472?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e7dc775e86376ea9e71a78c2adaddfe1152888fd4674ed35b3eed755d49da472?s=96&d=mm&r=g\",\"caption\":\"giusy\"},\"url\":\"https:\\\/\\\/www.pjpharma.it\\\/en\\\/author\\\/marketing\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Secol Antireflux: Clinical Study on Reflux and Heartburn","description":"Secol Antireflux clinical study: after 4 weeks, 75% of 20 adults achieved a reduction of at least 50% in their GERD-HRQL score.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/","og_locale":"en_US","og_type":"article","og_title":"Secol Antireflux: Clinical Study on Reflux and Heartburn","og_description":"Secol Antireflux clinical study: after 4 weeks, 75% of 20 adults achieved a reduction of at least 50% in their GERD-HRQL score.","og_url":"https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/","og_site_name":"PJ PHARMA","article_published_time":"2026-11-20T11:33:36+00:00","article_modified_time":"2026-11-20T11:43:34+00:00","og_image":[{"width":1920,"height":960,"url":"https:\/\/www.pjpharma.it\/wp-content\/uploads\/2026\/11\/Secol-Antireflusso-studio-clinico-su-reflusso-e-bruciore-1920x960-1.webp","type":"image\/webp"}],"author":"giusy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"giusy","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/#article","isPartOf":{"@id":"https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/"},"author":{"name":"giusy","@id":"https:\/\/www.pjpharma.it\/en\/#\/schema\/person\/68d46a7f1517c6578046391a7778943d"},"headline":"Secol Antireflux: clinical study on reflux and heartburn","datePublished":"2026-11-20T11:33:36+00:00","dateModified":"2026-11-20T11:43:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/"},"wordCount":543,"commentCount":0,"publisher":{"@id":"https:\/\/www.pjpharma.it\/en\/#organization"},"image":{"@id":"https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pjpharma.it\/wp-content\/uploads\/2026\/11\/Secol-Antireflusso-studio-clinico-su-reflusso-e-bruciore-1920x960-1.webp","keywords":["Clinical study","gastroesophageal reflux","GERD-HRQL","heartburn","Secol Antireflux"],"articleSection":["Clinical Studies"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/","url":"https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/","name":"Secol Antireflux: Clinical Study on Reflux and Heartburn","isPartOf":{"@id":"https:\/\/www.pjpharma.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/#primaryimage"},"image":{"@id":"https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pjpharma.it\/wp-content\/uploads\/2026\/11\/Secol-Antireflusso-studio-clinico-su-reflusso-e-bruciore-1920x960-1.webp","datePublished":"2026-11-20T11:33:36+00:00","dateModified":"2026-11-20T11:43:34+00:00","description":"Secol Antireflux clinical study: after 4 weeks, 75% of 20 adults achieved a reduction of at least 50% in their GERD-HRQL score.","breadcrumb":{"@id":"https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/#primaryimage","url":"https:\/\/www.pjpharma.it\/wp-content\/uploads\/2026\/11\/Secol-Antireflusso-studio-clinico-su-reflusso-e-bruciore-1920x960-1.webp","contentUrl":"https:\/\/www.pjpharma.it\/wp-content\/uploads\/2026\/11\/Secol-Antireflusso-studio-clinico-su-reflusso-e-bruciore-1920x960-1.webp","width":1920,"height":960},{"@type":"BreadcrumbList","@id":"https:\/\/www.pjpharma.it\/en\/secol-antireflux-clinical-study-reflux-heartburn\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pjpharma.it\/en\/"},{"@type":"ListItem","position":2,"name":"Secol Antireflux: clinical study on reflux and heartburn"}]},{"@type":"WebSite","@id":"https:\/\/www.pjpharma.it\/en\/#website","url":"https:\/\/www.pjpharma.it\/en\/","name":"PJPharma","description":"","publisher":{"@id":"https:\/\/www.pjpharma.it\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pjpharma.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.pjpharma.it\/en\/#organization","name":"PJPharma","url":"https:\/\/www.pjpharma.it\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pjpharma.it\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.pjpharma.it\/wp-content\/uploads\/2025\/07\/LOGO_PJ-17.png","contentUrl":"https:\/\/www.pjpharma.it\/wp-content\/uploads\/2025\/07\/LOGO_PJ-17.png","width":708,"height":700,"caption":"PJPharma"},"image":{"@id":"https:\/\/www.pjpharma.it\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.pjpharma.it\/en\/#\/schema\/person\/68d46a7f1517c6578046391a7778943d","name":"giusy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e7dc775e86376ea9e71a78c2adaddfe1152888fd4674ed35b3eed755d49da472?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e7dc775e86376ea9e71a78c2adaddfe1152888fd4674ed35b3eed755d49da472?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e7dc775e86376ea9e71a78c2adaddfe1152888fd4674ed35b3eed755d49da472?s=96&d=mm&r=g","caption":"giusy"},"url":"https:\/\/www.pjpharma.it\/en\/author\/marketing\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pjpharma.it\/en\/wp-json\/wp\/v2\/posts\/9640","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pjpharma.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pjpharma.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pjpharma.it\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pjpharma.it\/en\/wp-json\/wp\/v2\/comments?post=9640"}],"version-history":[{"count":1,"href":"https:\/\/www.pjpharma.it\/en\/wp-json\/wp\/v2\/posts\/9640\/revisions"}],"predecessor-version":[{"id":9642,"href":"https:\/\/www.pjpharma.it\/en\/wp-json\/wp\/v2\/posts\/9640\/revisions\/9642"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pjpharma.it\/en\/wp-json\/wp\/v2\/media\/9641"}],"wp:attachment":[{"href":"https:\/\/www.pjpharma.it\/en\/wp-json\/wp\/v2\/media?parent=9640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pjpharma.it\/en\/wp-json\/wp\/v2\/categories?post=9640"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pjpharma.it\/en\/wp-json\/wp\/v2\/tags?post=9640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}